About SynapDx Corp.
“SynapDx is a private company providing laboratory diagnostics to physicians who suspect children of developmental disorders, with the initial goal of enabling earlier detection of autism spectrum disorders (ASDs). The company collaborates with ASD and gene expression experts at leading institutions, including Boston Children’s Hospital. SynapDx was founded 2010 and is based in Southborough, Mass.”
2010
SynapDx Launched
SynapDx is developing a blood test designed to enable earlier detection of autism spectrum disorders (ASDs).
Headquarters: Lexington, Massachusetts
Founders: Stanley Lapidus (President), Jeffrey Luber (VP, Corporate Development)
Employees: 18
Investors: North Bridge Venture Partners, General Catalyst Partners, Laboratory Corporation of America, The Kraft Group, Bain Capital Ventures
Twitter: @synapdxcorp
LinkedIn: linkedin.com/company/844039
June 2, 2010
SynapDx Corp., a new Waltham company that aims to develop tests for the early detection of autism announced the completion of a $9 million round of financing.
Investing were Bain Capital Ventures, General Catalyst Partners, and North Bridge Venture Partners.
February 21, 2013
February 21, 2013
SynapDx Corporation’s CEO Stanley Lapidus Presents at Autism Speaks’ Inaugural Autism Investment Conference
March 2013
May 27, 2013
Kraft Group backs autism test startup SynapDx
The Kraft Group, owner of the New England Patriots and numerous other businesses, has made a “significant investment” into Southborough-based SynapDx, which is developing an early detection blood-based test for autism spectrum disorder. Amount not disclosed.
July 22, 2013
SynapDx Corporation Secures $15.4M in Funding Led by Google Ventures
SynapDx Corporation announced it had secured a $15.4 million funding round, led by Google Ventures. Foundation Medical Partners also joined the financing as a new investor alongside founding investors North Bridge Venture Partners and General Catalyst Partners.
December 2014
March 2, 2017
$32.4 million = Total Funding Amount
“One of the risks of biotech companies is that sometimes you have a hypothesis, and nature just disagrees with you. That’s what happened here,” said GV’s Krishna Yeshwant.
June 6, 2017
The company experimented with tests that analyzed DNA, RNA, metabolites and other biomarkers to determine which ones correlated with autism. But Tribble says the study failed to prove its potential to be both reliable and accurate, and the company shut down.
More With SynapDx
Loading…
Something went wrong. Please refresh the page and/or try again.
More With Stanley Lapidus
More With LabCorp
Loading…
Something went wrong. Please refresh the page and/or try again.
Note/Warning:
Autistic people have fought the inclusion of ABA in therapy for us since before Autism Speaks, and other non-Autistic-led autism organizations, started lobbying legislation to get it covered by insurances and Medicaid.
ABA is a myth originally sold to parents that it would keep their Autistic child out of an institution. Today, parents are told that with early intervention therapy their child will either be less Autistic or no longer Autistic by elementary school, and can be mainstreamed in typical education classes. ABA is very expensive to pay out of pocket. Essentially, Autism Speaks has justified the big price tag up front will offset the overall burden on resources for an Autistic’s lifetime. The recommendation for this therapy is 40 hours a week for children and toddlers.
The original study that showed the success rate of ABA to be at 50% has never been replicated. In fact, the study of ABA by United States Department of Defense was denounced as a failure. Not just once, but multiple times. Simply stated: ABA doesn’t work. In study after repeated study: ABA (conversion therapy) doesn’t work.
What more recent studies do show: Autistics who experienced ABA therapy are at high risk to develop PTSD and other lifelong trauma-related conditions. Historically, the autism organizations promoting ABA as a cure or solution have silenced Autistic advocates’ opposition. ABA is also known as gay conversion therapy.
The ‘cure’ for Autistics not born yet is the prevention of birth.
The ‘cure’ is a choice to terminate a pregnancy based on ‘autism risk.’ The cure is abortion. This is the same ‘cure’ society has for Down Syndrome.
This is eugenics 2021. Instead of killing Autistics and disabled children in gas chambers or ‘mercy killings’ like in Aktion T4, it’ll happen at the doctor’s office, quietly, one Autistic baby at a time. Different approaches yes, but still eugenics and the extinction of an entire minority group of people.
Fact: You can’t cure Autistics from being Autistic.
Fact: You can’t recover an Autistic from being Autistic.
Fact: You can groom an Autistic to mask and hide their traits. Somewhat. … however, this comes at the expense of the Autistic child, promotes Autistic Burnout (this should not be confused with typical burnout, Autistic Burnout can kill Autistics), and places the Autistic child at high risk for PTSD and other lifelong trauma-related conditions.
[Note: Autism is NOT a disease, but a neurodevelopmental difference and disability.]
Fact: Vaccines Do Not Cause Autism.
International Badass Activists 
One response to “SynapDx Corporation Timeline | Circa 2010 – 2017 #NotAnAutisticAlly #AutisticHistory”
[…] SynapDx Launched – Autism Blood Test research […]
LikeLike